NEW YORK, June 4, 2021 /PRNewswire/ -- Notice is hereby given that Monteverde & Associates PChas filed a class action lawsuit in the United States District Court for the Southern District of California, Ziegler v. GW Pharmaceuticals, PLC et al, Docket No. 3:21-cv-01019, on behalf of holders of American Depositary Shares of GW Pharmaceuticals, PLC, ("GW" or the "Company") (Nasdaq: GWPH) who held GW securities as of the record date, March 10, 2021 (the "Class Period"), and have been harmed by GW's and its board of directors' alleged violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") regarding the acquisition of GW (the "Merger") by Jazz Pharmaceuticals, PLC (Nasdaq: JAZZ).
On May 5, 2021, each GW ADS was canceled and converted into $200 in cash and 0.120360 Jazz Ordinary Shares (the "Merger Consideration"). The complaint alleges that the Merger Consideration harmed GW shareholders by providing them with less than the inherent value of the Company and that the Proxy Statement GW filed with the U.S. Securities and Exchange Commission to solicit shareholder approval of the Merger misled shareholders about the Company's financials and the Merger in violation of the Exchange Act.
If you wish to serve as lead plaintiff for the class, you must move the Court no later than August 3, 2021. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.
Click here for more information: http://monteverdelaw.com/case/gw-pharmaceuticals-plc. It is free and there is no cost or obligation to you.
Monteverde & Associates PC is a national class action securities and consumer litigation law firm that has recovered millions of dollarsfor shareholders and is committed to protecting investors and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017- 2019 an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017- 2020 Top Rated Lawyer.
Contact: Juan E. Monteverde, Esq.MONTEVERDE & ASSOCIATES PCThe Empire State Building 350 Fifth Ave, Suite 4405 New York, NY 10118 United States of America email@example.com Tel: (212) 971-1341
Attorney Advertising. (C) 2021 Monteverde & Associates PC. Prior results do not guarantee a similar outcome with respect to any future matter.
View original content to download multimedia: http://www.prnewswire.com/news-releases/monteverde--associates-pc-filed-a-class-action-lawsuit-on-behalf-of-shareholders-of-gw-pharmaceuticals-plc-in-the-southern-district-of-california-301306240.html
SOURCE Monteverde & Associates PC